PACS Group shares are trading higher after the company announced it will release its Q3 2025 results on November 19.

PACS Group Inc. to Release Third Quarter 2025 Financial Results

PACS Group Inc. will release its third quarter 2025 financial results on November 19, 2025, and will host a conference call at 5:30 p.m. ET to discuss the results. The financial results will be available on the company's website, and the call can be accessed via webcast. This announcement was originally published by PACS Group Inc. via Business Wire.

PACS Group Delays Quarterly Financial Report Filing

PACS Group Inc. has delayed filing its Q3 2025 Quarterly Report on Form 10-Q due to an ongoing Audit Committee investigation and restatement of financial statements for Q1 and Q2 2024. The company expects to file by November 19, 2025.

PACS Group Secures Forbearance Extension on Credit Agreement Through November 30

PACS Group Inc. has secured an extension of its forbearance agreement with Truist Bank and other lenders until November 30, 2025. This extension prevents lenders from exercising their rights under the credit agreement during the forbearance period. Additionally, landlords under the Omega Master Lease have agreed to forbear from enforcing their rights through the same date. The company is also working to meet SEC filing obligations to regain compliance with NYSE reporting requirements.

PACS Group (PACS): Assessing Valuation Following NYSE Extensions and Progress on Regulatory Challenges

PACS Group has secured NYSE extensions, indicating progress in overcoming regulatory challenges and improving stability. Despite a -69.92% total shareholder return over the past year, the stock has gained 8.3% in the last 90 days. With a P/E ratio of 21.3x, it aligns with the healthcare sector average, suggesting it is neither a bargain nor overpriced. However, a DCF analysis values it at $2.36, indicating potential overvaluation. Sustaining this rebound depends on continued regulatory progress and growth execution.